Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | CTSG | P08311 | 1/20 | 0.31 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.31 |
| ▸ | CMA1 | P23946 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2789197 | 0.89 | ALDH1A1 (0.55) | ALDH1A1KDM4EMEN1USP2LMNA | |
| SCHEMBL23827164 | 0.87 | ALDH1A1 (0.40) | ALDH1A1KDM4EMEN1USP2LMNA | |
| SCHEMBL3173473 | 0.84 | ALDH1A1 (0.48) | ALDH1A1KDM4EMEN1USP2LMNA | |
| SCHEMBL28040638 | 0.83 | — | — | |
| SCHEMBL14938147 | 0.81 | ALDH1A1 (0.46) | ALDH1A1LMNATSHRPRSS1CTSG | |
| SCHEMBL6887378 | 0.79 | ALDH1A1 (0.43) | ALDH1A1LMNATSHRPRSS1CTSG | |
| SCHEMBL19863302 | 0.79 | ALDH1A1 (0.43) | ALDH1A1LMNATSHRPRSS1CTSG | |
| SCHEMBL13663473 | 0.79 | — | — | |
| SCHEMBL7038108 | 0.78 | TSHR (0.44) | ALDH1A1KDM4EMEN1USP2LMNA | |
| SCHEMBL6501758 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116913580-A | Insulated wire, method of manufacturing the same, coil, and electronic apparatus | 奇美实业股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-116913584-A | Insulated wire, method of manufacturing the same, coil, and electronic apparatus | 奇美实业股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| US-20210388002-A1 | DIMETHOXYBENZENE COMPOUND ANALOGS, METHODS FOR ANALYZING SAID COMPOUNDS AND STANDARD PRODUCTS OF SAID COMPOUNDS | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2021-12-16 | — | — | US | disclosed |
| US-20210387990-A1 | METHOD FOR PRODUCING DIMETHOXYBENZENE COMPOUND | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2021-12-16 | — | — | US | disclosed |
| EP-3882248-A1 | DIMETHOXYBENZENE COMPOUND ANALOGS, METHODS FOR ANALYZING SAID COMPOUNDS AND STANDARD PRODUCTS OF SAID COMPOUNDS | Taiho Pharmaceutical Co., Ltd. (JP) | 2021-09-22 | — | — | EP | disclosed |
| CN-113260618-A | Dimethoxybenzene compound analogue, method for analyzing compound and standard substance of compound | 大鹏药品工业株式会社 | 2021-08-13 | — | — | CN | disclosed |
| EP-2990415-B1 | Cyclic beta defensins analogs for the treatment of infections | CEINGE BIOTECNOLOGIE AVANZATE S C A R L (IT) | 2018-11-28 | — | — | EP | disclosed |
| EP-2990415-A1 | Cyclic beta defensins analogs for the treatment of infections | Ceinge Biotecnologie Avanzate S.C. a R.L. (IT) | 2016-03-02 | — | — | EP | disclosed |
| US-8202448-B2 | Liquid-crystalline polyester resin composition and connector using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-06-19 | — | — | US | disclosed |
| US-20100163796-A1 | LIQUID-CRYSTALLINE POLYESTER RESIN COMPOSITION AND CONNECTOR USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-07-01 | — | — | US | disclosed |
| US-20100051999-A1 | LIQUID-CRYSTALLINE POLYESTER RESIN MIXTURE, AND REFLECTING PLATE AND LIGHT-EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-03-04 | — | — | US | disclosed |
| US-7381740-B2 | Exert the beneficial effects of melatonin including anti-oxidation, sedation, anesthesia, protection of organs to chemical, infectious and cardiovascular damage, and can be administered in a water-based vehicle | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2008-06-03 | — | — | US | disclosed |
| US-7009026-B2 | Method for producing a liquid crystalline polyester and the liquid crystalline polyester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-03-07 | — | — | US | disclosed |
| US-20040044171-A1 | Method for producing a liquid crystalline polyester and the liquid crystalline polyester | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-03-04 | — | — | US | disclosed |
| US-6171517-B1 | Rubber compounding formulation and method | UNIROYAL CHEMICAL COMPANY, INC. | 2001-01-09 | — | — | US | disclosed |
| EP-0742810-B1 | RUBBER COMPOUNDING FORMULATION AND METHOD | UNIROYAL CHEM CO INC (US) | 1999-04-21 | — | — | EP | disclosed |
| US-5622944-A | MODIFIED 17-HYDROXY STEROL; TRANSDERMAL ELECTROTRANSPORT ENHANCEMENT | AFFYMAX TECHNOLOGIES N.V. (GB) | 1997-04-22 | — | — | US | disclosed |
| EP-0742810-A1 | RUBBER COMPOUNDING FORMULATION AND METHOD | UNIROYAL CHEMICAL COMPANY, Inc. (US) | 1996-11-20 | — | — | EP | disclosed |
| WO-1995021214-A1 | RUBBER COMPOUNDING FORMULATION AND METHOD | UNIROYAL CHEMICAL COMPANY, INC. (US) | 1995-08-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210387990-A1 | METHOD FOR PRODUCING DIMETHOXYBENZENE COMPOUND | CYP1B1, PAH, CYP4B1 | ALDH1A1 40/4885KDM4E 935/4885MEN1 172/4885 |
| US-20210388002-A1 | DIMETHOXYBENZENE COMPOUND ANALOGS, METHODS FOR ANALYZING SAID COMPOUNDS AND STANDARD PRODUCTS OF SAID COMPOUNDS | DDC, PAH, DDT | ALDH1A1 12/4885KDM4E 919/4885MEN1 233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.